Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News PolyPid Ltd PYPD

Healthcare
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:PYPD)

PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference

GlobeNewswire February 28, 2024

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire February 14, 2024

PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial

GlobeNewswire February 12, 2024

PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024

GlobeNewswire January 31, 2024

PolyPid Announces Private Placement for $16 Million in Gross Proceeds

GlobeNewswire January 4, 2024

PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results

GlobeNewswire November 8, 2023

PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors

GlobeNewswire November 7, 2023

PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023

GlobeNewswire November 1, 2023

PolyPid Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

GlobeNewswire October 11, 2023
View More News ››

Opinion & Analysis (NDAQ:PYPD)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:PYPD)

PYPD .... Ka F'ing Booom !!!!!

Yeeeha !!!!!!!!!!!!!!!
Iseneschal - September 12, 2022

PYPD ..... How am I doing today there Mr. Stockhouse

LMFAO PYPD ..... Cha F'ing Ching  Cheers !
Iseneschal - September 12, 2022

PYPD ....heads up....Watch list

Heading into the gap  Cheers !
Iseneschal - September 12, 2022
View more Bullboard ››

Revive Therapeutics Ltd.

Revive Therapeutics Ltd.

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of ...
View More »